Literature DB >> 20223384

What is the optimal dose of epinephrine during cardiopulmonary resuscitation in a rat model?

Meng-Hua Chen1, Jun-Yu Lu, Lu Xie, Jun-Hui Zheng, Feng-Qing Song.   

Abstract

OBJECTIVE: Because different species may require different doses of drug to produce the same physiologic response, we were provoked to evaluate the dose-response of epinephrine during cardiopulmonary resuscitation (CPR) and identify what is the optimal dose of epinephrine in a rat cardiac arrest model.
METHODS: Rat cardiac arrest was induced via asphyxia, and then the effects of different doses of epinephrine (0.04, 0.2, and 0.4 mg/kg IV, respectively) and saline on the outcome of CPR were compared (n = 10/each group). The primary outcome measure was restoration of spontaneous circulation (ROSC), and the secondary was the change of spontaneous respiration and hemodynamics after ROSC.
RESULTS: Rates of ROSC were 9 of 10, 8 of 10, 7 of 10, and 1 of 10 in the low-dose, medium-dose, and high-dose epinephrine groups and saline group, respectively. The rates of withdrawal from the ventilator within 60 minutes in the low-dose (7 of 9) and medium-dose epinephrine groups (7 of 8) were higher than in the high-dose epinephrine group (1 of 7, P < .05). Mean arterial pressures were comparable, but the heart rate in the high-dose epinephrine group was the lowest among epinephrine groups after ROSC. These differences in part of time points reached statistical significance (P < .05).
CONCLUSION: Different doses of epinephrine produced the similar rate of ROSC, but high-dose epinephrine inhibited the recovery of spontaneous ventilation and caused relative bradycardia after CPR in an asphyxial rat model. Therefore, low and medium doses of epinephrine were more optimal for CPR in a rat asphyxial cardiac arrest model. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223384     DOI: 10.1016/j.ajem.2008.11.023

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

1.  Mitophagy in the Hippocampus Is Excessive Activated After Cardiac Arrest and Cardiopulmonary Resuscitation.

Authors:  Yang Huang; Xuhui Gao; Xiang Zhou; Biao Xie; Yu Zhang; Jian Zhu; ShuiBo Zhu
Journal:  Neurochem Res       Date:  2019-11-26       Impact factor: 3.996

2.  Intravenous lipid emulsion alters the hemodynamic response to epinephrine in a rat model.

Authors:  Stephanie Carreiro; Jared Blum; Gregory Jay; Jason B Hack
Journal:  J Med Toxicol       Date:  2013-09

3.  Global and regional differences in cerebral blood flow after asphyxial versus ventricular fibrillation cardiac arrest in rats using ASL-MRI.

Authors:  Tomas Drabek; Lesley M Foley; Andreas Janata; Jason Stezoski; T Kevin Hitchens; Mioara D Manole; Patrick M Kochanek
Journal:  Resuscitation       Date:  2014-04-12       Impact factor: 5.262

4.  On the Efficacy of Cardio-Pulmonary Resuscitation and Epinephrine Following Cyanide- and H2S Intoxication-Induced Cardiac Asystole.

Authors:  Annick Judenherc-HaouzI; Takashi Sonobe; Vikhyat S Bebarta; Philippe Haouzi
Journal:  Cardiovasc Toxicol       Date:  2018-10       Impact factor: 3.231

5.  Cyclosporine A Plus Ischemic Postconditioning Improves Neurological Function in Rats After Cardiac Resuscitation.

Authors:  Xiang Zhou; YanLiang Qu; GuoShen Gan; ShuiBo Zhu; Yang Huang; Yong Liu; Jian Zhu; Biao Xie; ZhiTian Tan
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

6.  The Effect of Adrenaline on the Mineral and Trace Element Status in Rats.

Authors:  Svitlana Shkurashivska; Hanna Ersteniuk
Journal:  Open Life Sci       Date:  2019-05-17       Impact factor: 0.938

Review 7.  Effects of prehospital adrenaline administration on out-of-hospital cardiac arrest outcomes: a systematic review and meta-analysis.

Authors:  Pongsakorn Atiksawedparit; Sasivimol Rattanasiri; Mark McEvoy; Colin A Graham; Yuwares Sittichanbuncha; Ammarin Thakkinstian
Journal:  Crit Care       Date:  2014-07-31       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.